Valuation: Becton, Dickinson and Company

Market Cap 49.6B 42.82B 40.17B 36.59B 68.8B 4,742B 69.75B 471B 185B 2,376B 186B 182B 7,903B P/E 2026 *
35.1x
P/E 2027 * 19.6x
Enterprise Value 65.48B 56.53B 53.04B 48.31B 90.83B 6,261B 92.09B 622B 244B 3,137B 246B 241B 10,434B EV / Sales 2026 *
3.39x
EV / Sales 2027 * 3.22x
Free-Float
73.18%
Yield 2026 *
2.15%
Yield 2027 * 2.19%
1 day+1.51%
1 week+1.94%
Current month+10.24%
1 month+15.81%
3 months+27.87%
6 months+2.70%
Current year-6.91%
1 week 176.28
Extreme 176.28
187
1 month 150
Extreme 150
187
Current year 139.58
Extreme 139.58
212.51
1 year 139.58
Extreme 139.58
212.51
3 years 139.58
Extreme 139.58
282.76
5 years 139.58
Extreme 139.58
286.33
10 years 139.58
Extreme 139.58
286.33
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Change 5-day change 1-year change 3-year change Capi.($)
+1.80%+1.94% - - 49.6B
-0.79%+1.61%-16.23%+5.18% 191B
-0.73%+1.33%-2.60%+11.08% 116B
-0.41%-3.84%+6.73%+73.62% 59.64B
-0.42%+1.08%+34.00%+70.00% 55.42B
-0.71%+1.37%-7.07%-33.92% 49.6B
-1.10%+1.27%+9.65%-17.67% 33.49B
-2.41%+3.16% - - 30.6B
-1.60%-0.79%-7.55%+24.99% 24.25B
-0.80%-1.57%+40.78%-11.77% 24.39B
Average -0.23%+0.63%+7.21%+15.19% 64.93B
Weighted average by Cap. +0.18%+0.81%-0.60%+15.51%

Financials

2026 *2027 *
Net sales 19.29B 16.65B 15.62B 14.23B 26.76B 1,845B 27.13B 183B 71.77B 924B 72.43B 70.86B 3,074B 19.73B 17.04B 15.98B 14.56B 27.37B 1,887B 27.75B 187B 73.42B 945B 74.09B 72.48B 3,144B
Net income 1.44B 1.24B 1.16B 1.06B 1.99B 137B 2.02B 13.64B 5.34B 68.82B 5.39B 5.28B 229B 2.34B 2.02B 1.89B 1.73B 3.25B 224B 3.29B 22.21B 8.7B 112B 8.78B 8.59B 373B
Net Debt 15.88B 13.71B 12.87B 11.72B 22.03B 1,519B 22.34B 151B 59.1B 761B 59.64B 58.35B 2,531B 13.95B 12.04B 11.3B 10.29B 19.35B 1,334B 19.62B 132B 51.91B 668B 52.38B 51.25B 2,223B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
17/08/26 USD 182.82 -0.25% 846
14/08/26 USD 183.28 +0.52% 339
13/08/26 USD 182.33 +0.57% 468
12/08/26 USD 181.29 +0.23% 145
11/08/26 USD 180.88 +1.24% 64
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
182.09USD
Average target price
194.42USD
Spread / Average Target
+6.77%

Quarterly revenue - Rate of surprise